AR3 is a Chemicals & Materials company. Its directors and officers file their transactions with ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for AR3 logged 2 filings by 1 insider.
Only sales appear on the open market, 2 sales in all totalling €15k, filed by 1 insider. The amount is not disclosed for 1 filing. Travis Beinke filed the largest sale, €15k, on 15 May 2026, which represents 0.091% of the company's market value.
For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 2 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 2 sales.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Culp Inc and Gold.com, Inc. also feature in our signals. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Analysts rate AR3 Strong Buy (bullish), based on 1 analysts. Average price target: A$0.39.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2024 · cache
2 of 2 declarations
AR3 is a company operating in the chemicals and materials sector, listed on the XASX. It specializes in the development and production of innovative chemical solutions.
Purchases our model currently ranks for the recommendations list.
All recommendations